The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move aimed at adjusting the trading price of its securities in U.S. markets, POMDOCTOR announced that a change in its American Depositary Share (ADS) ratio will become effective on June 22, 2026. According to reports, the representation will shift from one ADS for every 1/6 of an ordinary share to one ADS representing 3 Class A ordinary shares. This technical adjustment is equivalent to a 1-for-18 reverse ADS split and follows a preliminary announcement made by the company in late May.
Sign in to access this content
Sign InThis action comes as Chinese tech firms listed in the U.S. increasingly seek to maintain minimum listing requirements, as reverse splits are often utilized to nominally boost share prices and avoid potential delisting. In comparison to sector peers, other Chinese tech stocks like Alibaba and JD.com have seen mixed performance amid regulatory and economic pressures, with Alibaba (BABA) trading near $0.09 and JD.com (JD) around $29.20 per recent market data.
Traders should watch June 22, 2026, as the key date for the realignment of POM price levels. On the broader economic front, global markets are awaiting the UK Trade Balance and GDP data on June 12, which may influence general risk appetite in international markets ahead of the company's corporate action implementation.